JPS57136520A - Antiarteriosclerotic containing aminobenzoic acid derivative - Google Patents

Antiarteriosclerotic containing aminobenzoic acid derivative

Info

Publication number
JPS57136520A
JPS57136520A JP661282A JP661282A JPS57136520A JP S57136520 A JPS57136520 A JP S57136520A JP 661282 A JP661282 A JP 661282A JP 661282 A JP661282 A JP 661282A JP S57136520 A JPS57136520 A JP S57136520A
Authority
JP
Japan
Prior art keywords
day
antiarteriosclerotic
acid derivative
aminobenzoic acid
orally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP661282A
Other languages
Japanese (ja)
Other versions
JPS6254771B2 (en
Inventor
Chikao Yoshikumi
Fumio Hirose
Yoshio Omura
Takami Fujii
Masanori Ubusawa
Minoru Ohara
Kenichi Matsunaga
Takao Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP661282A priority Critical patent/JPS57136520A/en
Publication of JPS57136520A publication Critical patent/JPS57136520A/en
Publication of JPS6254771B2 publication Critical patent/JPS6254771B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: An antiarteriosclerotic that contains a specific aminobenzoic acid derivative, thus permitting long-term administration, because of its freeness of antibiotic activity and dusturbance of enterobacteria, with extremely high safety free from teratogenecity and allergic reactions.
CONSTITUTION: The objective drug contains a compound of the formula (R1 is residue of acylated mono- through trisaccharide), its salt or ester, such as methyl o-aminobenzoate-N-O-acetyl-D-mannoside, as an active ingredient. It can be administered orally or parenterally to men or animals, preferably orally. The dose of the compound of the formula to man is orally 0.5W200mg/kg/day or parenterally 0.1W100mg/kg/day and it is given by portions 1W4 times a day.
COPYRIGHT: (C)1982,JPO&Japio
JP661282A 1982-01-19 1982-01-19 Antiarteriosclerotic containing aminobenzoic acid derivative Granted JPS57136520A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP661282A JPS57136520A (en) 1982-01-19 1982-01-19 Antiarteriosclerotic containing aminobenzoic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP661282A JPS57136520A (en) 1982-01-19 1982-01-19 Antiarteriosclerotic containing aminobenzoic acid derivative

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP17194479A Division JPS5695197A (en) 1979-12-28 1979-12-28 Aminobenzoic acid derivative and physiologically active agent containing the same

Publications (2)

Publication Number Publication Date
JPS57136520A true JPS57136520A (en) 1982-08-23
JPS6254771B2 JPS6254771B2 (en) 1987-11-17

Family

ID=11643177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP661282A Granted JPS57136520A (en) 1982-01-19 1982-01-19 Antiarteriosclerotic containing aminobenzoic acid derivative

Country Status (1)

Country Link
JP (1) JPS57136520A (en)

Also Published As

Publication number Publication date
JPS6254771B2 (en) 1987-11-17

Similar Documents

Publication Publication Date Title
ES485188A1 (en) Diphenylbutyl-piperzinecarboxamides
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
IL101544A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
HUP0003571A2 (en) 6,9-bridged erythromycin derivatives
JPS5721320A (en) Blood sugar level depressing agent
DE3568440D1 (en) New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
FR2429019A1 (en) DRUGS CONTAINING 1-B-D-ARABINOFURANOSYLCYTOSINE-5'-PHOSPHATE ESTERS
GB1015787A (en) Tris-(p-methoxyphenyl)ethylene derivatives
JPS5781486A (en) Benzo(ij)quinolidine-2-carboxylic acid derivative
JPS57136519A (en) Antidiabetic containing aminobenzoic acid derivative
JPS57136520A (en) Antiarteriosclerotic containing aminobenzoic acid derivative
JPS5735515A (en) Immunoregulating agent
JPS57136523A (en) Antipyretic analgesic containing aminobenzoic acid derivative
JPS57136524A (en) Anti-inflammatory containing aminobenzoic acid derivative
JPS57136521A (en) Hypotensor containing aminobenzoic acid derivative
ES8100249A1 (en) Novel hydroxamic acid compounds, method for preparation thereof and medicaments containing such compounds
JPS57136522A (en) Antitumor agent containing aminobenzoic acid derivative
JPS5716898A (en) Prostaglandin controller containing aminobenzoic derivative
JPS5533453A (en) Preventive and remedy for infectious disease of fish
JPS5634625A (en) Antitumorigenic agent
JPS5634626A (en) Anti-inflammatory
JPS5655397A (en) Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative
GB949523A (en) ºÔ-(acyloxyphenoxy)-benzoic acid derivatives
JPS57181012A (en) Drug composed of polyprenyl compound
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride